Xeris Biopharma: Q2 Earnings Snapshot

August 10, 2022 GMT

CHICAGO (AP) _ Xeris Biopharma Holdings, Inc. (XERS) on Wednesday reported a loss of $26.2 million in its second quarter.

The Chicago-based company said it had a loss of 19 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

The company posted revenue of $25.3 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $25.5 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS